Article info

Download PDFPDF

330 Redirecting glucose usage during in vitro expansion improves the in vivo persistence and function of adoptive T cell therapies for cancer
Free

Authors

Citation

Frisch A, Wang Y, Wang Y, et al
330 Redirecting glucose usage during in vitro expansion improves the in vivo persistence and function of adoptive T cell therapies for cancer

Publication history

  • First published November 7, 2022.
Online issue publication 
November 07, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.